Bioray Biotech Co., Ltd (TPEX:7561)

Bioray Biotech Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 8, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	615	635	930	901	1,290	826
Market Cap Growth	-0.59%	-31.64%	3.17%	-30.18%	56.23%	-
Enterprise Value	512	586	911	896	1,226	756
Last Close Price	20.80	21.30	30.90	29.76	46.51	29.94
PE Ratio	20.21	634.18	-	1802.11	-	-
PS Ratio	2.67	3.15	4.85	4.73	8.72	5.29
PB Ratio	1.40	1.51	2.14	2.00	3.55	2.22
P/TBV Ratio	1.40	1.51	2.15	2.01	3.58	2.26
P/FCF Ratio	19.69	47.32	-	-	-	-
P/OCF Ratio	18.35	38.16	-	363.62	146.17	493.43
EV/Sales Ratio	2.22	2.90	4.75	4.70	8.29	4.84
EV/EBITDA Ratio	8.68	48.59	-	56.76	230.50	80.79
EV/FCF Ratio	16.37	43.61	-	-	-	-
Debt / Equity Ratio	0.12	0.20	0.16	0.22	0.15	0.17
Debt / EBITDA Ratio	0.87	4.26	13.55	4.68	4.99	4.11
Debt / FCF Ratio	1.64	6.39	-	-	-	-
Asset Turnover	0.43	0.37	0.34	0.36	0.31	0.32
Inventory Turnover	2.17	2.40	2.10	2.24	1.72	2.10
Quick Ratio	5.30	5.33	3.52	2.77	2.20	2.33
Current Ratio	7.15	6.98	5.00	3.69	2.83	3.02
Return on Equity (ROE)	7.12%	0.23%	-2.61%	0.12%	-2.16%	-0.38%
Return on Assets (ROA)	4.13%	-0.50%	-2.12%	-0.04%	-1.08%	-0.03%
Return on Capital (ROIC)	4.44%	-0.53%	-2.29%	-0.04%	-1.19%	-0.03%
Return on Capital Employed (ROCE)	7.40%	-0.90%	-3.90%	-0.10%	-2.10%	-0.10%
Earnings Yield	4.96%	0.16%	-1.24%	0.06%	-0.56%	-0.01%
FCF Yield	5.08%	2.11%	-1.16%	-6.34%	-0.48%	-5.97%
Dividend Yield	-	-	-	0.67%	-	-
Buyback Yield / Dilution	2.01%	0.83%	-7.37%	-4.67%	-0.14%	0.09%
Total Shareholder Return	2.01%	0.83%	-7.37%	-3.99%	-0.14%	0.09%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.